Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
648
mi
from 91732
Albuquerque, NM
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
University of New Mexico
648
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
2440
mi
from 91732
Albany, NY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Capital Region Retina, PLLC
2440
mi
from 91732
Albany, NY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
2450
mi
from 91732
Lynbrook, NY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Opthalmic Consultants of LI
2450
mi
from 91732
Lynbrook, NY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
2434
mi
from 91732
New York, NY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Vitreous-Retina-Macula
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
2435
mi
from 91732
New York, NY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Eye Associates; NewYork-Presbyterian Hospital/Weill Cornell Medical Center
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
2187
mi
from 91732
Orchard Park, NY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Western New York
2187
mi
from 91732
Orchard Park, NY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
2321
mi
from 91732
Syracuse, NY
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Vit Surgeons/Central NY
2321
mi
from 91732
Syracuse, NY
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
2004
mi
from 91732
Asheville, NC
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
West Carolina Retinal AssocPA
2004
mi
from 91732
Asheville, NC
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
2102
mi
from 91732
Charlotte, NC
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Char Eye Ear &Throat Assoc
2102
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
1880
mi
from 91732
Cincinnati, OH
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Cincinnati Eye Institute
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
2041
mi
from 91732
Cleveland, OH
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Assoc. of Cleveland
2041
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
2036
mi
from 91732
Cleveland, OH
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation; Cole Eye Institute
2036
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
1960
mi
from 91732
Columbus, OH
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
OSU Eye Physicians and Surgeons, LLC.
1960
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
740
mi
from 91732
Eugene, OR
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Oregon Retina, LLP
740
mi
from 91732
Eugene, OR
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
827
mi
from 91732
Portland, OR
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Northwest, PC
827
mi
from 91732
Portland, OR
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
2281
mi
from 91732
Camp Hill, PA
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Pennsylvania Retinal Spec.
2281
mi
from 91732
Camp Hill, PA
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
2123
mi
from 91732
West Mifflin, PA
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Associates in Ophthalmology
2123
mi
from 91732
West Mifflin, PA
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
2172
mi
from 91732
Ladson, SC
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Charleston Neuroscience Inst
2172
mi
from 91732
Ladson, SC
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
1601
mi
from 91732
Germantown, TN
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Charles Retina Institution
1601
mi
from 91732
Germantown, TN
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
1762
mi
from 91732
Nashville, TN
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Tennessee Retina, P.C.
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
1057
mi
from 91732
Abilene, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
W Texas Retina Consultants PA
1057
mi
from 91732
Abilene, TX
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
1205
mi
from 91732
Arlington, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Texas Retina Associates
1205
mi
from 91732
Arlington, TX
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
1211
mi
from 91732
Austin, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Austin Retina Associates
1211
mi
from 91732
Austin, TX
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
1211
mi
from 91732
Austin, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Research Center
1211
mi
from 91732
Austin, TX
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
1221
mi
from 91732
DeSoto, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Specialists
1221
mi
from 91732
DeSoto, TX
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
1357
mi
from 91732
Houston, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
1180
mi
from 91732
San Antonio, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Med Center Ophthalmology Assoc
1180
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
1340
mi
from 91732
The Woodlands, TX
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston
1340
mi
from 91732
The Woodlands, TX
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
570
mi
from 91732
Salt Lake City, UT
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Utah
570
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
2207
mi
from 91732
Charlottesville, VA
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Univ of Virginia Ophthalmology
2207
mi
from 91732
Charlottesville, VA
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
2270
mi
from 91732
Richmond, VA
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Eye Surgeons of Richmond Inc. dba Virginia Eye Institute
2270
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
939
mi
from 91732
Spokane, WA
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Spokane Eye Clinical Research
939
mi
from 91732
Spokane, WA
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
2122
mi
from 91732
Morgantown, WV
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
West Virginia University Eye Institute
2122
mi
from 91732
Morgantown, WV
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
2174
mi
from 91732
Florence, SC
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Palmetto Retina Center, LLC
2174
mi
from 91732
Florence, SC
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
1907
mi
from 91732
Marietta, GA
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Georgia Retina, P.C.
1907
mi
from 91732
Marietta, GA
Click here to add this to my saved trials
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
2412
mi
from 91732
Edison, NJ
A Study of RO6867461 in Participants With Center-involving Diabetic Macular Edema
A Multiple-center, Multiple-dose, Randomized, Active Comparator−Controlled, Double-masked, Parallel Group, 36-week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO6867461 Administered Intravitreally in Patients With Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
New Jersey Retina Research Foundation
2412
mi
from 91732
Edison, NJ
Click here to add this to my saved trials
Optimization of CRT Using an ECG Vest
Optimization of Cardiac Resynchronization Therapy Using an ECG Vest
Status: Enrolling
Updated:  12/31/1969
1515
mi
from 91732
Saint Paul, MN
Optimization of CRT Using an ECG Vest
Optimization of Cardiac Resynchronization Therapy Using an ECG Vest
Status: Enrolling
Updated: 12/31/1969
United Heart and Vascular Clinic
1515
mi
from 91732
Saint Paul, MN
Click here to add this to my saved trials
LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry
Prospective Registry of Patients With Ischemic Heart Failure Using the LifeVest Wearable Cardioverter Defibrillator (WEARIT-III)
Status: Enrolling
Updated:  12/31/1969
2244
mi
from 91732
Rochester, NY
LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry
Prospective Registry of Patients With Ischemic Heart Failure Using the LifeVest Wearable Cardioverter Defibrillator (WEARIT-III)
Status: Enrolling
Updated: 12/31/1969
Univ of Rochester Medical Center
2244
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/31/1969
mi
from 91732
Long Beach, CA
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/31/1969
Theravance Biopharma Investigational Site
mi
from 91732
Long Beach, CA
Click here to add this to my saved trials
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/31/1969
mi
from 91732
Farmington Hills, MI
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/31/1969
Theravance Biopharma Investigational Site
mi
from 91732
Farmington Hills, MI
Click here to add this to my saved trials
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/31/1969
mi
from 91732
Berlin, NJ
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/31/1969
Theravance Biopharma Investigational Site
mi
from 91732
Berlin, NJ
Click here to add this to my saved trials
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/31/1969
2351
mi
from 91732
New York, NY
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/31/1969
Theravance Biopharma Investigational Site
2351
mi
from 91732
New York, NY
Click here to add this to my saved trials
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/31/1969
mi
from 91732
Nashville, TN
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/31/1969
Theravance Biopharma Investigational Site
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  12/31/1969
mi
from 91732
Dallas, TX
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
A Phase 2 Study to Assess the Effect of TD-9855 in Subjects With Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 12/31/1969
Theravance Biopharma Investigational Site
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
STOP Heart Disease in Breast Cancer Survivors Trial
Statin Therapy Operates to Prevent (STOP) Heart Disease in Breast Cancer Survivors Trial
Status: Enrolling
Updated:  12/31/1969
13
mi
from 91732
Los Angeles, CA
STOP Heart Disease in Breast Cancer Survivors Trial
Statin Therapy Operates to Prevent (STOP) Heart Disease in Breast Cancer Survivors Trial
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease
THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease
Status: Enrolling
Updated:  12/31/1969
356
mi
from 91732
San Francisco, CA
THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease
THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
356
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
827
mi
from 91732
Portland, OR
Oregon Health and Science University
827
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"
A Phase 2, Placebo Controlled, Randomized, Double-Blind, Parallel-Arm Study to Evaluate Efficacy and Safety of BMS- 986141 For the Prevention of Recurrent Brain Infarction in Subjects Receiving Acetylsalicylic Acid (ASA) Following Acute Ischemic Stroke or Transient Ischemic Attack
Status: Enrolling
Updated:  12/31/1969
2194
mi
from 91732
Chapel Hill, NC
Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"
A Phase 2, Placebo Controlled, Randomized, Double-Blind, Parallel-Arm Study to Evaluate Efficacy and Safety of BMS- 986141 For the Prevention of Recurrent Brain Infarction in Subjects Receiving Acetylsalicylic Acid (ASA) Following Acute Ischemic Stroke or Transient Ischemic Attack
Status: Enrolling
Updated: 12/31/1969
Local Institution
2194
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"
A Phase 2, Placebo Controlled, Randomized, Double-Blind, Parallel-Arm Study to Evaluate Efficacy and Safety of BMS- 986141 For the Prevention of Recurrent Brain Infarction in Subjects Receiving Acetylsalicylic Acid (ASA) Following Acute Ischemic Stroke or Transient Ischemic Attack
Status: Enrolling
Updated:  12/31/1969
2345
mi
from 91732
Newark, DE
Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"
A Phase 2, Placebo Controlled, Randomized, Double-Blind, Parallel-Arm Study to Evaluate Efficacy and Safety of BMS- 986141 For the Prevention of Recurrent Brain Infarction in Subjects Receiving Acetylsalicylic Acid (ASA) Following Acute Ischemic Stroke or Transient Ischemic Attack
Status: Enrolling
Updated: 12/31/1969
Local Institution
2345
mi
from 91732
Newark, DE
Click here to add this to my saved trials
Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"
A Phase 2, Placebo Controlled, Randomized, Double-Blind, Parallel-Arm Study to Evaluate Efficacy and Safety of BMS- 986141 For the Prevention of Recurrent Brain Infarction in Subjects Receiving Acetylsalicylic Acid (ASA) Following Acute Ischemic Stroke or Transient Ischemic Attack
Status: Enrolling
Updated:  12/31/1969
2307
mi
from 91732
Baltimore, MD
Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"
A Phase 2, Placebo Controlled, Randomized, Double-Blind, Parallel-Arm Study to Evaluate Efficacy and Safety of BMS- 986141 For the Prevention of Recurrent Brain Infarction in Subjects Receiving Acetylsalicylic Acid (ASA) Following Acute Ischemic Stroke or Transient Ischemic Attack
Status: Enrolling
Updated: 12/31/1969
Local Institution
2307
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials